Skip to main content

iBio, Inc.

For the period ended Sep 30, 2026. Filed Nov 10, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 10, 2026

IBIO$0.78-1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I. FINANCIAL INFORMATION3
Item 1.Financial Statements:
​Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and June 30, 20263
​Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended September 30, 2026 and 20254
​Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 30, 2026 and 20255
​Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2026 and 20256
​Notes to the Condensed Consolidated Financial Statements7
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations37
Item 3.Quantitative and Qualitative Disclosures About Market Risk48
Item 4.Controls and Procedures48
PART II. OTHER INFORMATION49
Item 1.Legal Proceedings49
Item 1A.Risk Factors49
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds50
Item 3.Defaults Upon Senior Securities51
Item 4.Mine Safety Disclosures51
Item 5.Other Information51
Item 6.Exhibits52
SIGNATURES53
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.